HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.25
Day range
$0.24 - $0.26
Year range
$0.17 - $0.48
Market cap
381.00M USD
Avg Volume
3.68M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
BNN Bloomberg
11 hours ago
S&P/TSX composite falls amid bank losses, U.S. stocks tumble as yields rise
0.90%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 200.00K | -43.98% |
Operating expense | 7.07M | 0.60% |
Net income | -26.83M | -38.48% |
Net profit margin | -13.41K | -147.19% |
Earnings per share | — | — |
EBITDA | -13.87M | 3.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.56M | 55.15% |
Total assets | 30.61M | 4.39% |
Total liabilities | 125.86M | 34.52% |
Total equity | -95.25M | — |
Shares outstanding | 1.54B | — |
Price to book | -3.61 | — |
Return on assets | -119.02% | — |
Return on capital | 204.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -26.83M | -38.48% |
Cash from operations | -13.89M | -68.75% |
Cash from investing | -513.00K | -191.48% |
Cash from financing | 11.56M | -0.53% |
Net change in cash | 244.00K | 320.69% |
Free cash flow | -4.95M | -23.91% |
